T. M. C. Tan, Y. Chen, K. H. Kong, J. Bai, Y. Li, S. G. Lim, T. H. Ang and Y. Lam, “Synthesis and the Biological Evaluation of 2-Benzenesulfonylalkyl-5-substituted- sul-fanyl-[1,3,4]-oxadiazoles as Potential Anti-Hepatitis B Virus Agents,” Antiviral Research, Vol. 71, No. 1, 2006, pp. 7-14. doi:10.1016/j.antiviral.2006.02.007

has been cited by the following article:

• TITLE: Synthesis and Screening of New 5-Substituted-1,3,4-oxadiazole-2-thioglycosides as Potent Anticancer Agents

  AUTHORS: Mamdouh A .Z. Abu-Zaied, Galal A. M. Nawwar, Randa H. Swellem, Shahinaz H. El-Sayed

  KEYWORDS: 1, 3, 4-Oxadiazoles; Thioglycosides; Acyclic Sugars; Antitumor

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.3 No.2, April 25, 2012

  ABSTRACT: A series of newly 1,3,4-oxadiazole-2-thioglycoside derivatives were synthesized. The key step of this protocol is the coupling between 5-herteroaryl-1,3,4-oxadiazole-2-thione and activated sugars (cyclic or acyclic sugar analogues) in the presence of basic medium. Among of the synthesized compounds, compounds 7, 10, 11 and 13 were screened for them in vitro anticancer activity against four human cancer cells. MCF-7 (Breast), HEPG2 (Liver), HCT116 (Colon) and HEP2 (Larynx) carcinoma cell lines with IC50 values ranging from 2.08 - 8.72 μg/well. Compounds 11 and 13 were highly specific and potent for four cell lines (MCF-7, HCT116, HEPG2 and HEP2).